Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|May 9, 2001
Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian studyG Civardi, D Vallisa, R Bertè, et al.
Haematologica|May 1, 1995
Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsyL Cavanna, F Artioli, D Vallisa, et al.
Leukemia|August 24, 2004
Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disordersE Morra, C Cesana, C Klersy, et al.
Haematologica|September 1, 1993
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trialM Brugiatelli, M Federico, P G Gobbi, et al.
Haematologica|November 1, 1996
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL)P G Gobbi, C Pieresca, L Cavanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trialA Passardi, O Nanni, D Tassinari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemiaM Luppi, G Longo, M G Ferrari, et al.
Haematologica|February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registryC Stelitano, L Baldini, C Pieresca, et al.
Haematologica|July 18, 2000
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's diseaseP G Gobbi, C Broglia, R Bertè, et al.
Leukemia|April 7, 1998
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ETS Sacchi, L Gugliotta, F Papineschi, et al.
Pageof 10